Cargando…

Characterization of the Portuguese population diagnosed with retinoblastoma

The purpose of this study is to characterize demographically and genetically the Portuguese population with retinoblastoma; to report the clinical stage at presentation and its impact on survival and ocular preservation rate and, finally, to assess the incidence of retinoblastoma in Portugal. Retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Castela, Guilherme, Providência, Joana, Monteiro, Madalena, Silva, Sonia, Brito, Manuel, Sá, Joaquim, Oliveiros, Barbara, Murta, Joaquim Neto, Correa, Zelia, Branco, Miguel Castelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921246/
https://www.ncbi.nlm.nih.gov/pubmed/35288594
http://dx.doi.org/10.1038/s41598-022-08326-6
_version_ 1784669295214592000
author Castela, Guilherme
Providência, Joana
Monteiro, Madalena
Silva, Sonia
Brito, Manuel
Sá, Joaquim
Oliveiros, Barbara
Murta, Joaquim Neto
Correa, Zelia
Branco, Miguel Castelo
author_facet Castela, Guilherme
Providência, Joana
Monteiro, Madalena
Silva, Sonia
Brito, Manuel
Sá, Joaquim
Oliveiros, Barbara
Murta, Joaquim Neto
Correa, Zelia
Branco, Miguel Castelo
author_sort Castela, Guilherme
collection PubMed
description The purpose of this study is to characterize demographically and genetically the Portuguese population with retinoblastoma; to report the clinical stage at presentation and its impact on survival and ocular preservation rate and, finally, to assess the incidence of retinoblastoma in Portugal. Retrospective observational study including children consecutively diagnosed with retinoblastoma at the Portuguese National Referral Center of Intraocular Tumors, between October 2015 and October 2020. Twenty-eight children were diagnosed with retinoblastoma at our center, 15 hereditary from which 12 presented with bilateral retinoblastoma and 3 were unilateral. The overall mean age at diagnosis was 13.6 ± 11.1 months with hereditary retinoblastomas diagnosed slightly earlier at 9.6 ± 6.3 months. A familial history of retinoblastoma was found in only 4 (14.3%) of the cases. A pathogenic mutation in the RB1 gene was found in 13 (46.4%) of the children. The most frequent sign at referral was leukocoria in 71.4% of patients. Considering the ICRB classification of the tumors, 84.6% of non-hereditable hereditary retinoblastomas were referred to our center in advanced stages. In the group of hereditable retinoblastomas 86.7% presented with one of the eyes with advanced intraocular retinoblastoma. Fourteen children had one eye enucleated due to retinoblastoma. No deaths were registered during the study period. Considering the incidence analysis, we registered a year-of-birth controlled incidence analysis of 4.04 per 100.000 living births (IC 95% 1.59–6.49). This is the first characterization of the Portuguese Population diagnosed with Retinoblastoma in the National Reference Center.
format Online
Article
Text
id pubmed-8921246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89212462022-03-16 Characterization of the Portuguese population diagnosed with retinoblastoma Castela, Guilherme Providência, Joana Monteiro, Madalena Silva, Sonia Brito, Manuel Sá, Joaquim Oliveiros, Barbara Murta, Joaquim Neto Correa, Zelia Branco, Miguel Castelo Sci Rep Article The purpose of this study is to characterize demographically and genetically the Portuguese population with retinoblastoma; to report the clinical stage at presentation and its impact on survival and ocular preservation rate and, finally, to assess the incidence of retinoblastoma in Portugal. Retrospective observational study including children consecutively diagnosed with retinoblastoma at the Portuguese National Referral Center of Intraocular Tumors, between October 2015 and October 2020. Twenty-eight children were diagnosed with retinoblastoma at our center, 15 hereditary from which 12 presented with bilateral retinoblastoma and 3 were unilateral. The overall mean age at diagnosis was 13.6 ± 11.1 months with hereditary retinoblastomas diagnosed slightly earlier at 9.6 ± 6.3 months. A familial history of retinoblastoma was found in only 4 (14.3%) of the cases. A pathogenic mutation in the RB1 gene was found in 13 (46.4%) of the children. The most frequent sign at referral was leukocoria in 71.4% of patients. Considering the ICRB classification of the tumors, 84.6% of non-hereditable hereditary retinoblastomas were referred to our center in advanced stages. In the group of hereditable retinoblastomas 86.7% presented with one of the eyes with advanced intraocular retinoblastoma. Fourteen children had one eye enucleated due to retinoblastoma. No deaths were registered during the study period. Considering the incidence analysis, we registered a year-of-birth controlled incidence analysis of 4.04 per 100.000 living births (IC 95% 1.59–6.49). This is the first characterization of the Portuguese Population diagnosed with Retinoblastoma in the National Reference Center. Nature Publishing Group UK 2022-03-14 /pmc/articles/PMC8921246/ /pubmed/35288594 http://dx.doi.org/10.1038/s41598-022-08326-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Castela, Guilherme
Providência, Joana
Monteiro, Madalena
Silva, Sonia
Brito, Manuel
Sá, Joaquim
Oliveiros, Barbara
Murta, Joaquim Neto
Correa, Zelia
Branco, Miguel Castelo
Characterization of the Portuguese population diagnosed with retinoblastoma
title Characterization of the Portuguese population diagnosed with retinoblastoma
title_full Characterization of the Portuguese population diagnosed with retinoblastoma
title_fullStr Characterization of the Portuguese population diagnosed with retinoblastoma
title_full_unstemmed Characterization of the Portuguese population diagnosed with retinoblastoma
title_short Characterization of the Portuguese population diagnosed with retinoblastoma
title_sort characterization of the portuguese population diagnosed with retinoblastoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921246/
https://www.ncbi.nlm.nih.gov/pubmed/35288594
http://dx.doi.org/10.1038/s41598-022-08326-6
work_keys_str_mv AT castelaguilherme characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT providenciajoana characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT monteiromadalena characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT silvasonia characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT britomanuel characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT sajoaquim characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT oliveirosbarbara characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT murtajoaquimneto characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT correazelia characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma
AT brancomiguelcastelo characterizationoftheportuguesepopulationdiagnosedwithretinoblastoma